While reporting financial results for the first quarter, Danaher Corp. (DHR) on Thursday slashed its earnings outlook for the full-year 2019, reflecting the dilution related to its recent equity offerings to fund the GE Biopharma acquisition, partially offset by first quarter 2019 performance.
from RTT - Earnings http://bit.ly/2Dl7hVP
via IFTTT
No comments:
Post a Comment